查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466706

脸部注射剂市场：按类型、最终用户划分 - 2024-2030 年全球预测

Facial Injectables Market by Type (Anti-aging Injections, Dermal Fillers), End User (Beauty Clinics, Dermatology Clinics, Dermatology Research Institutes) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年脸部注射剂市场规模为173亿美元，预计2024年将达193亿美元，2030年将达377.2亿美元，复合年增长率为11.77%。

脸部注射剂是透过注射进行的医疗程序，旨在增强脸部美观、使皮肤恢復活力并治疗各种老化征兆。这些是微创手术，可以暂时改善肤色、纹理和结构。对微创美容疗程的需求增加、产品开发的技术进步以及可支配收入的增加使更多的人能够负担得起此类手术。然而，手术的高成本以及注射后併发症和副作用的风险是阻碍潜在客户的重大问题。也就是说，个人化医疗的进步，例如根据个人面部解剖结构和期望结果量身定制的注射剂，再加上对这些治疗的安全性和有效性的持续研究，预计将为面部护理提供未开发的潜力并创造脸部注射剂的机会。

主要市场统计
基准年[2023] 173亿美元
预测年份 [2024] 193亿美元
预测年份 [2030] 377.2亿美元
复合年增长率（%） 11.77%

由于能够恢復脸部体积，抗老化注射的偏好激增

抗老化老注射包括一系列旨在透过抚平皱纹和恢復脸部体积来减少老化征兆的产品。它的作用是放鬆脸部肌肉和填充皱纹，并由医疗保健专业人员管理。 A 型肉毒桿菌毒素是一种神经调节剂，用于暂时放鬆脸部肌肉。 A 型肉毒桿菌是最受欢迎的抗老化疗法之一，用于减少动态皱纹的出现，尤其是上脸上的皱纹，例如额头纹、鱼尾纹和眉间纹。聚左旋乳酸（PLLA）是一种生物分解性的合成材料，用作微粒。作为一种刺激性填充剂，PLLA 被注入皮肤深处，随着时间的推移刺激胶原蛋白的产生，逐渐增厚皮肤并抚平皱纹。真皮填充剂是用于增加体积、改变脸部轮廓和填充皱纹的注射。常见的治疗区域是嘴唇、脸颊、法令纹和木偶纹。填料由多种物质组成，其中一些是天然衍生的，一些是合成的。胶原蛋白填充剂由人类或动物胶原蛋白製成，用于取代体内随着老龄化而减少的天然胶原蛋白。这些填充剂可以改善细纹并提供适度的提拉效果，但它们往往比其他填充剂分解得更快。透明质酸是皮肤中天然存在的物质，有助于保持水分并创造饱满、水润的外观。透明质酸填充剂用于脸部注射，因为它们与身体高度相容，并且随着时间的推移自然溶解。透明质酸填充剂通常用于唇部塑形、轮廓以及中度至重度脸部褶皱和皱纹的治疗。合成填充剂由实验室製造的物质製成，这些物质并非天然存在于皮肤中。这些填充剂，如羟基磷灰石钙、聚乳酸和聚甲基丙烯酸甲酯珠，比使用被身体吸收的物质的填充剂提供更持久的效果，用于深层皱纹、减少体积和脸部轮廓。

最终使用者：皮肤科诊所越来越多地采用脸部注射剂

美容诊所是脸部注射剂的重要组成部分，因为它们专门从事整容手术。这些设施通常提供各种非手术美容治疗，包括肉毒桿菌、真皮填充剂和其他填充剂，旨在增强面部特征并减少老化征兆。皮肤科诊所是脸部注射剂的重要最终使用者。这些设施由皮肤科医生运营，并提供注射剂，作为更广泛的皮肤护理服务的一部分。这些设施的脸部注射剂用于美容和治疗目的，包括治疗多汗症和某些类型的偏头痛等疾病。皮肤病学研究机构对于推进脸部注射产品和技术至关重要。这些研究机构将优先考虑脸部注射剂，这些注射剂在皮肤病学方面具有创新和突破的潜力。我们也可以直接与製造商合作进行临床试验和研究，以评估长期疗效和安全性。将优先考虑允许研究人员探索新人群、适应症和给药方法的产品。医院使用脸部注射剂的重点是重组或治疗，而不是美容。脸部注射剂也可用于创伤或手术后的康復，或治疗偏头痛或出汗过多等疾病。医院喜欢多功能、安全且经济高效的产品，尤其是在有健康保险和预算限制的情况下。

区域洞察

在消费者意识不断提高、人口老化以及强大的美容文化的推动下，美洲的脸部注射剂市场正在不断发展。公司不断创新并投资于研发，以获得竞争优势，更持久、更安全的填料的最新专利就证明了这一点。供应商也越来越多地客製化他们的产品和服务，以适应不同种族群体和个人的偏好。此外，由于消费者重视自然效果，供应商正在采用更精緻、更精确的技术和产品。由于监管限制、文化观念和经济状况的差异，欧盟国家的脸部注射剂市场差异很大。偏好自然外观和保守的整容方法是欧盟市场的普遍特征。欧盟医疗设备法规 (MDR) 等监管改革正在重塑产业内的标准和实践。中东地区的情况多种多样，由于许多国家在整容手术上的人均支出很高，因此占了很大的需求比例。非洲市场潜力巨大，一些国家正在经历都市化和经济开拓。这两个地区的抗老化治疗意识不断增强，推动了脸部注射剂市场的发展。亚太地区脸部注射剂市场正在快速成长，想要改善外表的中年人和年轻人对整容手术的接受度迅速提高。市场也见证了本土投资利用中阶不断增长的购买力以及挑战国际品牌的国内企业的崛起。此外，消费者更喜欢高品质、技术先进的产品，新註射剂的早期采用就证明了这一点。该国的法规也向市场通报美容医学的安全性和准确性。

FPNV定位矩阵

FPNV定位矩阵对于评估脸部注射剂市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对脸部注射剂市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.脸部注射剂市场的市场规模和预测是多少？

2.在脸部注射剂市场预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.脸部注射剂市场的技术趋势和法规结构是什么？

4.脸部注射剂市场主要供应商的市场占有率是多少？

5.进入脸部注射剂市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人民可支配收入增加，整容需求增加
      • 世界各地的消费者越来越重视自己的外表
      • 人们对微创手术的兴趣日益浓厚
    • 抑制因素
      • 整容手术的有限报销政策
    • 机会
      • 引入新型填充剂和抗衰老肉毒桿菌注射疗法并获得监管部门核准
      • 化妆品旅游的兴起
    • 任务
      • 关于脸部注射产品和相关副作用的严重监管问题
  • 市场区隔分析
    • 类型：抗老化老注射因其恢復面部体积的能力而变得越来越受欢迎
    • 最终使用者：皮肤科诊所越来越多地采用脸部注射剂
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章脸部注射剂市场：按类型

  • 抗老化注射
  • 真皮填充剂

第七章脸部注射剂市场：依最终用户分类

  • 美容诊所
  • 皮肤科诊所
  • 皮肤科研究所
  • 医院

第八章 北美、南美脸部注射剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区脸部注射剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东、非洲脸部注射剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • DAXXIFY 成为第一个被《时代》杂誌评为最佳发明的脸部注射剂
    • JUVEDERM 的 SKINVIVE 获得美国FDA核准
    • Symatese 与美国Evolus 合作推出新的 HA 真皮填充剂系列

第12章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-0355054AC48C

[188 Pages Report] The Facial Injectables Market size was estimated at USD 17.30 billion in 2023 and expected to reach USD 19.30 billion in 2024, at a CAGR 11.77% to reach USD 37.72 billion by 2030.

Facial injectables are medical treatments administered through injections to enhance facial aesthetics, rejuvenate skin, and treat various signs of aging. They are minimally invasive procedures that can temporarily improve skin tone, texture, and structure. The rising demand for minimally invasive aesthetic treatments, technological advancements in product development, and increased disposable income enable more individuals to afford such procedures. However, the high cost of procedures and the risk of complications and adverse effects post-injection is a significant concerns that can deter potential clients. Nevertheless, advancements in personalized medicine, such as customized injectables tailored to individual facial anatomy and desired outcomes, offer untapped potential coupled with ongoing research into the safety and efficacy of these treatments, which is expected to create lucrative opportunities for the facial injectables market.

KEY MARKET STATISTICS
Base Year [2023] USD 17.30 billion
Estimated Year [2024] USD 19.30 billion
Forecast Year [2030] USD 37.72 billion
CAGR (%) 11.77%

Type: Burgeoning preference for anti-aging injections due to its ability to restore facial volumes

Anti-aging injections encompass a range of products designed to decrease the signs of aging by smoothing wrinkles and restoring facial volume. They work by relaxing the facial muscles or filling in wrinkles and are administered by healthcare professionals. Botulinum Toxin A is a neuromodulator used to relax facial muscles temporarily. It is one of the most popular anti-aging treatments for lowering the appearance of dynamic wrinkles, particularly in the upper face, such as forehead lines, crow's feet, and frown lines. Poly-L-Lactic Acid (PLLA) is a biodegradable synthetic substance used as microparticles. As a stimulatory filler, PLLA is administered to the deeper layers of the skin to help stimulate the skin's production of collagen over time, gradually increasing skin thickness and smoothing wrinkles. Dermal fillers are injectable products utilized to add volume, change the contours of the face, and fill in wrinkles. Common areas for treatment comprise the lips, cheeks, nasolabial folds, and marionette lines. Fillers are composed of various substances, some naturally occurring and some synthetic. Collagen fillers are derived from either human or animal collagen and are used to supplement the body's natural collagen, which depletes with age. These fillers can improve the appearance of fine lines and wrinkles and provide a moderate lifting effect, but they tend to break down faster than other filler types. Hyaluronic acid is a naturally arising substance in the skin that retains moisture and creates a plump and hydrated look. Hyaluronic acid fillers are used for facial injections because of their compatibility with the body and can dissolve naturally over time. They are commonly used for lip augmentation, contouring, and treating medium to severe facial folds and wrinkles. Synthetic fillers comprise lab-made substances that do not naturally occur in the skin. These fillers, such as calcium hydroxylapatite, polylactic acid, and polymethylmethacrylate beads, provide longer-lasting results than those with substances that are absorbed by the body and are used for deep wrinkles, volume loss, and facial contouring.

End User: Evolving adoption of facial injectables by dermatology clinics

Beauty clinics represent a significant segment of facial injectables, given their specialization in cosmetic procedures. These establishments commonly provide a variety of non-surgical aesthetic treatments, including Botox, dermal fillers, and other injectables aimed at enhancing facial features and reducing signs of aging. Dermatology clinics are a critical end-user of facial injectables. These medical facilities are operated by board-certified dermatologists who administer injectables as part of a broader range of skin health services. Facial injectables in these settings are used for aesthetic enhancement and therapeutic purposes, such as treating medical conditions, including hyperhidrosis or certain types of migraines. Dermatology Research Institutes are pivotal in advancing facial injectable products and techniques. These institutions prioritize facial injectables that have the potential for innovation and breakthroughs in dermatological science. They may work directly with manufacturers in clinical trials or studies to evaluate long-term efficacy and safety. Preference is given to products that allow researchers to explore new populations, indications, or delivery methods. Hospitals' use of facial injectables revolves around reconstructive or therapeutic treatments rather than cosmetic enhancements. Patients may receive facial injectables for rehabilitation after traumatic injuries or surgeries or for the treatment of medical conditions such as migraines or excessive sweating. Hospitals prefer versatile products, have a strong safety record, and are cost-effective, especially when dealing with medical insurance and budget constraints.

Regional Insights

The facial injectables market is evolving in the Americas, driven by heightened consumer awareness, a growing aging population, and a strong culture of cosmetic enhancement. There is a significant investment in R&D, with companies constantly innovating to gain a competitive edge, as seen in the latest patents for longer-lasting and safer fillers. Providers are also increasingly tailoring their products and services to cater to diverse ethnic groups and individual preferences. Furthermore, consumers value natural-looking results, prompting providers to adopt techniques and products that deliver subtlety and precision. The facial injectables market across EU countries varies widely due to differing regulatory restrictions, cultural perceptions, and economic status. A preference for natural appearance and conservative approaches to cosmetic procedures generally distinguishes the EU market. Regulatory innovations such as the EU's Medical Device Regulation (MDR) are reshaping standards and practices within the industry. The MEA region presents a diverse landscape, with the Middle East accounting for a substantial share of demand due to the high per capita expenditure on cosmetic procedures in many countries. The African market shows potential with rising urbanization and economic development in certain countries. Both regions exhibit an increased awareness of anti-aging treatments, driving the market for facial injectables. The Asia-Pacific facial injectables market is burgeoning, with a sharp growth in the acceptance of aesthetic procedures among middle-aged and younger cohorts looking to enhance their appearances. The market is also witnessing local investments and the emergence of domestic players challenging international brands, capitalizing on the growing middle class's purchasing power. Furthermore, consumers prefer high-quality and technologically advanced products, demonstrated by their quick adoption of novel injectables. The country's regulatory emphasis also informs the market on safety and precision in aesthetic medicine.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Facial Injectables Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Facial Injectables Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Facial Injectables Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Advanced Dermatology and Cosmetic Surgery, ALPHAEON Corporation, Anika Therapeutics, Inc, Antares Pharma, Inc. by Halozyme Therapeutics, Inc., Bausch Health Companies Inc., Becton, Dickinson and Company, Bloomage BioTechnology Corporation Limited, Eisai Co., Ltd., Fidia Farmaceutici S.p.A., Galderma Laboratories, L.P., Galderma S.A., Inovio Pharmaceuticals Inc., Ipsen Pharma, Johnson & Johnson Services, Inc., Mastelli Srl, Medytox Inc., Merz Pharma GmbH & Co KGaA, Novartis AG, Pfizer Inc., Prollenium Medical Technologies Inc., Remedium Korea, Sanofi S.A., Sinclair Pharma Group, Suneva Medical, Inc., and Zimmer Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Facial Injectables Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Anti-aging Injections
      • Botulinum Toxin A
      • Poly-L-Lactic Acid (PLLA) Micro Particles
    • Dermal Fillers
      • Collagen Fillers
      • Hyaluronic Acid
      • Synthetic Fillers
  • End User
    • Beauty Clinics
    • Dermatology Clinics
    • Dermatology Research Institutes
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Facial Injectables Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Facial Injectables Market?

3. What are the technology trends and regulatory frameworks in the Facial Injectables Market?

4. What is the market share of the leading vendors in the Facial Injectables Market?

5. Which modes and strategic moves are suitable for entering the Facial Injectables Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Disposable Income Among People and Increased Demand for Cosmetic Procedures
      • 5.1.1.2. Increasing Focus on Physical Appearance Among Consumers Globally
      • 5.1.1.3. Rising Inclination Toward Minimally Invasive Procedures Among People
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Reimbursement Policies Supporting Cosmetic Procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of New Fillers and Anti-Aging Botulinum Toxin Injection Therapies coupled with Regulatory Approvals
      • 5.1.3.2. Rise in the Cosmetic Tourism
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Regulatory Concerns about Facial Injectable Products and Relative Side Effects
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Burgeoning preference for anti-aging injections due to its ability to restore facial volumes
    • 5.2.2. End User: Evolving adoption of facial injectables by dermatology clinics
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Facial Injectables Market, by Type

  • 6.1. Introduction
  • 6.2. Anti-aging Injections
  • 6.3. Dermal Fillers

7. Facial Injectables Market, by End User

  • 7.1. Introduction
  • 7.2. Beauty Clinics
  • 7.3. Dermatology Clinics
  • 7.4. Dermatology Research Institutes
  • 7.5. Hospitals

8. Americas Facial Injectables Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Facial Injectables Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Facial Injectables Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. DAXXIFY Becomes First Facial Injectable to be Named to TIME's Best Inventions
    • 11.3.2. SKINVIVE by JUVEDERM Receives U.S. FDA Approval
    • 11.3.3. Symatese Announces Its Partnership With Evolus In The USA Regarding Its New Range Of HA Dermal Fillers

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. FACIAL INJECTABLES MARKET RESEARCH PROCESS
  • FIGURE 2. FACIAL INJECTABLES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FACIAL INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. FACIAL INJECTABLES MARKET DYNAMICS
  • FIGURE 7. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. FACIAL INJECTABLES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. FACIAL INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FACIAL INJECTABLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FACIAL INJECTABLES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL FACIAL INJECTABLES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 104. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 111. CHINA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 112. CHINA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 119. INDIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 120. INDIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 127. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 128. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 135. JAPAN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 136. JAPAN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 143. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 144. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 152. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 159. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 160. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 175. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 176. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 183. THAILAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 184. THAILAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 191. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 192. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 209. DENMARK FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 210. DENMARK FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 217. EGYPT FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 218. EGYPT FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 225. FINLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 226. FINLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 233. FRANCE FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 234. FRANCE FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 241. GERMANY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 242. GERMANY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 249. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 250. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 257. ITALY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 258. ITALY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 266. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 273. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 274. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 281. NORWAY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 282. NORWAY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 289. POLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 290. POLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 297. QATAR FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 298. QATAR FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 299. QATAR FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 300. QATAR FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 305. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 306. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 307. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 308. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 314. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 316. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 322. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 325. SPAIN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. SPAIN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 329. SPAIN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 330. SPAIN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 331. SPAIN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 332. SPAIN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 333. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 334. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 337. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 338. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 339. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 340. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 342. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 346. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 348. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 349. TURKEY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. TURKEY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY FACIAL IN